|
ITGB8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.756100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.820000E-04 |
| Normal-vs-Stage2 |
9.490800E-01 |
| Normal-vs-Stage3 |
1.736440E-03 |
| Normal-vs-Stage4 |
1.223160E-01 |
| Stage1-vs-Stage2 |
5.586100E-02 |
| Stage1-vs-Stage3 |
7.844800E-01 |
| Stage1-vs-Stage4 |
2.499200E-01 |
| Stage2-vs-Stage3 |
7.767700E-02 |
| Stage2-vs-Stage4 |
3.535000E-01 |
| Stage3-vs-Stage4 |
2.123200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54699999999064E-05 |
| Normal-vs-AfricanAmerican |
1.198780E-01 |
| Normal-vs-Asian |
1.170840E-01 |
| Caucasian-vs-AfricanAmerican |
7.389400E-01 |
| Caucasian-vs-Asian |
1.695790E-01 |
| AfricanAmerican-vs-Asian |
3.827000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.950990E-01 |
| Normal-vs-Female |
6.26259999999546E-05 |
| Male-vs-Female |
2.521700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.22040000000301E-05 |
| Normal-vs-Age(41-60Yrs) |
4.320800E-03 |
| Normal-vs-Age(61-80Yrs) |
4.284600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.143800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.086200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.507700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.225200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.848410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.712800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.238000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.916400E-01 |
| Classical-VS-Follicular |
1.31450406115619E-13 |
| Classical-VS-Other |
3.402000E-01 |
| Classical-VS-Normal |
1.10500000261027E-08 |
| Tall-VS-Follicular |
2.99600000031042E-07 |
| Tall-VS-Other |
2.262800E-01 |
| Tall-VS-Normal |
9.631700E-04 |
| Follicular-VS-Other |
1.027030E-01 |
| Follicular-VS-Normal |
3.392600E-04 |
| Other-VS-Normal |
6.899400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.408000E-01 |
| Normal-vs-N1 |
1.807820E-02 |
| N0-vs-N1 |
8.330200E-02 |
|
|
